Posttransplantation lymphoproliferative disorders treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone chemotherapy

Background. Posttransplantation lymphoproliferative disorders after solid organ transplantation are a serious complication occurring in 1–10% of patients. Different therapies have been used, but the optimal treatment is unknown. There is relatively little information in the literature on the experience with cytotoxic chemotherapy.

[1]  T M Grogan,et al.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[2]  A. Fischer,et al.  Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. , 1991, The New England journal of medicine.

[3]  R. Fisher,et al.  Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.

[4]  M. Treat,et al.  Colonic lymphoma as a cause of massive rectal bleeding in a cardiac transplant recipient. , 1990, The Journal of cardiovascular surgery.

[5]  T. Starzl,et al.  The diagnosis and treatment of posttransplant lymphoproliferative disorders. , 1988, Current problems in surgery.

[6]  T. Starzl,et al.  REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY , 1984, The Lancet.

[7]  S. Leech,et al.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. , 1982, The New England journal of medicine.

[8]  H. Balfour,et al.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. , 1982, The New England journal of medicine.

[9]  J. Rosai,et al.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. , 1981, Cancer research.

[10]  C. Coltman,et al.  Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma , 1976, Cancer.

[11]  R. Stratta,et al.  Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. , 1989, The American journal of medicine.

[12]  J. Locker,et al.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. , 1988, The American journal of pathology.

[13]  M. Nalesnik,et al.  The diagnosis and treatment of post transplant lymphoproliferative disorders , 1988 .